Free · Every Tuesday · Five minutes

Health news,filtered for signal.

The latest worthwhile longevity and health news, checked for evidence and explained without the hype. No daily noise. No miracle claims.

  • Primary sources
  • One-click unsubscribe
  • No spam

The archive

Latest Briefs

Every published issue stays here, free to open and easy to share. Start with the latest issue below.

Get the next issue
#08Published
6 Oct 20263 min

Liver senolytics, muscle lipids and AMPK

A phase-2 MASH fibrosis signal, a cardiolipin recovery path, and direct AMPK lifespan gains.

Read this Brief
#07Published
29 Sept 20263 min

Senescence scores, mouth microbes and sleep

A blood proxy for senescence burden, an oral bacterium linked to slower aging, and a shared sleep path.

Read this Brief
#06Published
22 Sept 20264 min

Exercise mood, aging-rate clues and flexible diets

A middle-age trial, a faster path to test longevity drugs, and many healthy eating patterns.

Read this Brief
#05Published
15 Sept 20264 min

Calorie cuts, organ clocks and lonely sleep waves

Three September papers on ageing blood markers, organ clocks, and sleep-wave integrity.

Read this Brief
#04Published
8 Sept 20265 min

A prominent safety warning, and the evidence behind it

Plus a frailty trial, Bhutan's rabies milestone and an Lp(a) outcome miss.

Read this Brief
#03Published
1 Sept 20265 min

A new pancreatic-cancer approval rests on a real survival result

Plus why a refill is not adherence, and what a retraction changes.

Read this Brief
#02Published
25 Aug 20265 min

Why a younger biological-age score is not proof of better health

Why responsive ageing clocks are signals rather than health verdicts, plus an Alzheimer blood panel and a null stroke-care trial.

Read this Brief
#01Published
18 Aug 20265 min

A once-daily GLP-1 pill has moved beyond an early study

What 52-week results add to a peer-reviewed oral GLP-1 study, plus tissue ageing, shelf-stable plasma and the Result Ladder.

Read this Brief

Our filter

Useful enough to read. Honest enough to trust.

Primary sources first

Papers, registries, regulators and guidelines verify the claim, not social posts or press-release excitement.

Limits stay visible

Every major story explains what the evidence does not prove, plus important uncertainty and conflicts.

No filler

Each Tuesday, we focus on the most worthwhile evidence in a clear five-minute read.

The signal, without the hype

Get the next Brief.

Free, every Tuesday. Confirm once and you’re in.

Join the Brief